COGNOPTIX
Cognoptix is creating and developing an innovative, non-invasive eye test to assist in the early diagnosis of Alzheimer's Disease. Cognoptix's goal is to provide clinicians with a quick, predictive, reliable, inexpensive, and widely available test, enabling early diagnosis and treatment. The company was founded in 2001 and headquartered in Marlborough, Massachusetts.
COGNOPTIX
Industry:
Biotechnology Health Care Health Diagnostics Medical Device Therapeutics
Founded:
2001-01-01
Address:
Marlborough, Massachusetts, United States
Country:
United States
Website Url:
http://www.cognoptix.com
Total Employee:
1+
Status:
Active
Contact:
508-251-1546
Email Addresses:
[email protected]
Total Funding:
46.35 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
BioShai
BioShai is a simple blood test for the early diagnosis of Parkinson's disease.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
NeuroQuest
Developing biomarkers for early diagnosis of Alzheimer’s disease
RightAir
RightAir is developing noninvasive ventilators for COPD patients.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Investors List
LaunchPad Venture
LaunchPad Venture investment in Venture Round - Cognoptix
Sidecar Fund2
Sidecar Fund2 investment in Venture Round - Cognoptix
New York Angels
New York Angels investment in Venture Round - Cognoptix
Harvard Business School Alumni Angels of Greater NY
Harvard Business School Alumni Angels of Greater NY investment in Venture Round - Cognoptix
Nobska Point Capital
Nobska Point Capital investment in Venture Round - Cognoptix
Alopexx Enterprises
Alopexx Enterprises investment in Venture Round - Cognoptix
LaunchPad Venture
LaunchPad Venture investment in Series D - Cognoptix
Inventages Venture Capital Investment Inc.
Inventages Venture Capital Investment Inc. investment in Series D - Cognoptix
Alopexx Enterprises
Alopexx Enterprises investment in Series D - Cognoptix
Maine Angels
Maine Angels investment in Debt Financing - Cognoptix
Official Site Inspections
http://www.cognoptix.com Semrush global rank: 8.2 M Semrush visits lastest month: 353
- Host name: box2120.bluehost.com
- IP address: 70.40.216.90
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "Cognoptix"
Cognoptix - Crunchbase Company Profile & Funding
Cognoptix is creating and developing an innovative, non-invasive eye test to assist in the early diagnosis of Alzheimer's Disease. Cognoptix's goal is to provide clinicians with a quick, predictive, reliable, inexpensive, and widely available …See details»
About Cognoptix
Cognoptix’ goal is to provide clinicians with a highly accurate, reliable, inexpensive, convenient and widely available test that can be performed quickly on-site in the comfort of a physician’s office, to enable swift intervention and …See details»
Cognoptix Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Cognoptix. Use the PitchBook Platform to explore the full profile.See details»
Cognoptix, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Cognoptix, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 5 news, Disease Domain:Nervous System Diseases, Technology ...See details»
Cognoptix Company Profile - Office Locations, Competitors, …
Cognoptix has 5 employees at their 1 location and $43.1 m in total funding,. See insights on Cognoptix including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Neuroptix Corporation | VentureRadar
Cognoptix is creating and developing an innovative non-invasive and predictive eye scanning test for the early detection and diagnosis of Alzheimer's Disease. Cognoptix's goal is to provide …See details»
Cognoptix - Funding, Financials, Valuation & Investors
Cognoptix develops non-invasive eye tests for the early diagnosis of alzheimer disease.See details»
Cognoptix Announces Formation of a New Board of Directors
Dec 30, 2020 Cognoptix Announces Formation of a New Board of Directors MARLBOROUGH, Mass. , Dec. 30, 2020 — Cognoptix is a breakthrough diagnostics company developing an …See details»
Cognoptix - VentureRadar
Cognoptix's goal is to provide clinicians with a predictive, reliable, inexpensive and widely available test that can be performed quickly and accurately by a general practitioner in an …See details»
Cognoptix - Contacts, Employees, Board Members, Advisors
Cognoptix develops non-invasive eye tests for the early diagnosis of alzheimer disease.See details»
A pioneer in creating and developing a simple, innovative, non …
Cognoptix’s technology has demonstrated successful preclinical and clinical results as the company develops its diagnostic platform, consisting of a laser eye scanning device combined …See details»
Cognoptix - Overview, News & Similar companies | ZoomInfo.com
View Cognoptix (www.cognoptix.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Cognoptix - Tech Stack, Apps, Patents & Trademarks
The intellectual property of Cognoptix includes 11 registered patents primarily in the ' Medical Or Veterinary Science; Hygiene ' category, according to IPqwery. Additionally, Cognoptix has …See details»
Technology - Cognoptix
Cognoptix’ SAPPHIRE platform is a compact, easy to use, clinical device for in situ patient examination in the comfort of a doctor’s office. The combined platform is currently available in …See details»
Cognoptix, Inc. (Cognoptix, Inc.) - 药物管线_专利_临床试验_投融营 …
了解Cognoptix, Inc. (Cognoptix, Inc.)公司的药物管线，治疗领域，技术平台，以及它的1项临床试, 5篇新闻和1篇文献，疾病领域:神经系统疾病，技术平台:小分子化药，其他体内诊断药物，药 …See details»
Cognistx: An Applied AI Company
At Cognistx, our data science and engineering team builds adaptive, multi-strategy Artificial Intelligence (AI) systems to solve today’s most challenging business problems. With our …See details»
News - Cognoptix
Aug 10, 2021 COMPANY NEWS Cognoptix Investor PresentationDecember 2021 Read Now “Cognoptix: Pioneering the Early Detection of Alzheimer’s Disease”Cognoptix was recently …See details»
Discover Cognoptix - Cognoptix
Subscribe to our company news email list and receive Cognoptix news as it is released. To protect your privacy, your email address will be used only for this news distribution list.See details»